Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme

This study reports the initial experience at the University of California San Francisco (UCSF) with tumor resection and permanent, low-activity iodine 125 ((125)I) brachytherapy in patients with progressive or recurrent glioblastoma multiforme (GM) and compares these results to those of similar pati...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Larson, David A., Suplica, Jeffrey M., Chang, Susan M., Lamborn, Kathleen R., McDermott, Michael W., Sneed, Penny K., Prados, Michael D., Wara, William M., Nicholas, M. Kelly, Berger, Mitchel S.
Format: Artigo
Jezik:Inglês
Izdano: Duke University Press 2004
Teme:
Clinical Investigations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1871978/
https://ncbi.nlm.nih.gov/pubmed/15134626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/S1152851703000425
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items